基因组癌症测试和医疗决策：大型语言模型如何处理信息差距？］

Harefuah Pub Date : 2025-03-01

Arni Gershman, Or Degany, Rotem Sisso-Avron

{"title":"基因组癌症测试和医疗决策：大型语言模型如何处理信息差距？］","authors":"Arni Gershman, Or Degany, Rotem Sisso-Avron","doi":"","DOIUrl":null,"url":null,"abstract":"Introduction: Clinicians and patients are offered a variety of genomic tests intended to assess the prognosis of cancer. Among these is the \"Decipher\" test for prostate cancer. A 71-year-old patient with prostate cancer was referred for testing by his treating doctor. The test results suggested reclassification of the patient from the intermediate-risk group for death and disease complications to the high-risk group.","PeriodicalId":101459,"journal":{"name":"Harefuah","volume":"164 3","pages":"140-142"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[GENOMIC CANCER TESTS AND MEDICAL DECISION-MAKING: HOW DO LARGE LANGUAGE MODELS HANDLE INFORMATION GAPS?]\",\"authors\":\"Arni Gershman, Or Degany, Rotem Sisso-Avron\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Clinicians and patients are offered a variety of genomic tests intended to assess the prognosis of cancer. Among these is the \\\"Decipher\\\" test for prostate cancer. A 71-year-old patient with prostate cancer was referred for testing by his treating doctor. The test results suggested reclassification of the patient from the intermediate-risk group for death and disease complications to the high-risk group.\",\"PeriodicalId\":101459,\"journal\":{\"name\":\"Harefuah\",\"volume\":\"164 3\",\"pages\":\"140-142\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Harefuah\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Harefuah","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

临床医生和患者提供各种基因组测试旨在评估癌症的预后。其中包括前列腺癌的“破译”测试。一位71岁的前列腺癌患者被他的主治医生推荐去做检查。测试结果提示将患者从死亡和疾病并发症的中危组重新分类为高危组。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[GENOMIC CANCER TESTS AND MEDICAL DECISION-MAKING: HOW DO LARGE LANGUAGE MODELS HANDLE INFORMATION GAPS?]

Introduction: Clinicians and patients are offered a variety of genomic tests intended to assess the prognosis of cancer. Among these is the "Decipher" test for prostate cancer. A 71-year-old patient with prostate cancer was referred for testing by his treating doctor. The test results suggested reclassification of the patient from the intermediate-risk group for death and disease complications to the high-risk group.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Harefuah

自引率

0.00%

发文量